Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/173508
Title: | Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study |
Author: | Yacovo, Silvana Di Saumoy, Maria Sánchez Quesada, José Luís Navarro, Antonio Sviridov, Dmitri Javaloyas de Morlius, Manuel Vila, Ramon Vernet, Anton Low, Hann Peñafiel, Judith García, Benito Ordoñez Llanos, Jordi Podzamczer Palter, Daniel |
Keywords: | Infeccions per VIH Marcadors bioquímics Colesterol Lípids HIV infections Biochemical markers Cholesterol Lipids |
Issue Date: | 20-Aug-2020 |
Publisher: | Public Library of Science (PLoS) |
Abstract: | Objective: To assess the effect of HIV infection and combined antiretroviral therapy (c-ART) on various proatherogenic biomarkers and lipids and to investigate their relationship with subclinical atherosclerosis in a cohort of treatment-naive HIV-infected patients. Methods: We performed a prospective, comparative, multicenter study of 2 groups of treatment-naive HIV-infected patients (group A, CD4>500 cells/mu L, not starting c-ART; and group B, CD4<500 cells/mu L, starting c-ART at baseline) and a healthy control group. Laboratory analyses and carotid ultrasound were performed at baseline and at months 12 and 24. The parameters measured were low-density lipoprotein (LDL) particle phenotype, lipoprotein-associated phospholipase A2 (Lp-PLA2), interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), sCD14, sCD163, monocyte chemoattractant protein-1(MCP-1), and asymmetric dimethylarginine (ADMA). A linear mixed model based on patient clusters was used to assess differences in biomarkers between the study groups and over time. Results: The study population comprised 62 HIV-infected patients (group A, n = 31; group B, n = 31) and 22 controls. Age was 37 (30-43) years, and 81% were men. At baseline, the HIV-infected patients had a worse LDL particle phenotype and higher plasma concentration of sCD14, sCD163, hs-CRP, and LDL-Lp-PLA2 than the controls. At month 12, there was an increase in total cholesterol (p = 0.002), HDL-c (p = 0.003), and Apo A-I (p = 0.049) and a decrease in sCD14 (p = <0.001) and sCD163 (p<0.001), although only in group B. LDL particle size increased in group B at month 24 (p = 0.038). No changes were observed in group A or in the healthy controls. Common carotid intima-media thickness increased in HIV-infected patients at month 24 (Group A p = 0.053; group B p = 0.048). Plasma levels of sCD14, sCD163, and hs-CRP correlated with lipid values. Conclusions: In treatment-naive HIV-infected patients, initiation of c-ART was associated with an improvement in LDL particle phenotype and inflammatory/immune biomarkers, reaching values similar to those of the controls. HIV infection was associated with progression of carotid intima-media thickness. |
Note: | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0237739 |
It is part of: | PLoS One, 2020, vol. 15, num. 8, p. e0237739 |
URI: | http://hdl.handle.net/2445/173508 |
Related resource: | https://doi.org/10.1371/journal.pone.0237739 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Di YacovoS.pdf | 1.5 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License